MoneyWorks4Me

Parmax Pharma - Quaterly Results

14 Aug 2024 Evaluate
The total revenue for the June 2024 quarter zoomed 458.29% to Rs. 78.16 millions as compared to Rs. 14.00 millions during the year-ago period.The Total Profit for the quarter ended June 2024 of Rs. 0.12 millions grew from Rs.-11.79 millions Operating profit Margin for the quarter ended June 2024 improved to 5.21% as compared to -6.38% of corresponding quarter ended June 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 78.16 14.00 458.29 78.16 14.00 458.29 110.53 154.24 -28.34
Other Income 0.08 0.14 -42.86 0.08 0.14 -42.86 0.48 0.40 20.00
PBIDT 5.21 -6.38 -181.66 5.21 -6.38 -181.66 -33.23 22.93 -244.92
Interest 1.13 1.22 -7.38 1.13 1.22 -7.38 6.22 3.69 68.56
PBDT 4.08 -7.60 -153.68 4.08 -7.60 -153.68 -39.45 19.24 -305.04
Depreciation 3.96 4.19 -5.49 3.96 4.19 -5.49 17.12 18.79 -8.89
PBT 0.12 -11.79 -101.02 0.12 -11.79 -101.02 -56.57 0.45 -12671.11
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.95 1.50 -36.67
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.95 -0.35 -371.43
PAT 0.12 -11.79 -101.02 0.12 -11.79 -101.02 -57.52 -1.05 5378.10
Equity 37.41 37.41 0.00 37.41 37.41 0.00 37.41 37.41 0.00
PBIDTM(%) 6.67 -45.57 -114.63 6.67 -45.57 -114.63 -30.06 14.87 -302.23
Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..